BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 2674332)

  • 1. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer.
    Hu CY; Delclos GL; Chan W; Du XL
    Med Oncol; 2011 Dec; 28(4):1062-74. PubMed ID: 20714945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro.
    Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y; Furukawa Y
    Jpn J Cancer Res; 2001 Jan; 92(1):74-82. PubMed ID: 11173547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatic metastases from colorectal cancer: systemic chemotherapy.
    Leyland-Jones B; Burdette-Radoux S
    J Gastrointest Surg; 1997; 1(6):576-82. PubMed ID: 9834394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of colorectal cancer. Current guidelines and future prospects for drug therapy.
    Labianca R; Pessi MA; Zamparelli G
    Drugs; 1997 Apr; 53(4):593-607. PubMed ID: 9098662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
    Ragnhammar P; Blomgren H
    Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
    [No Abstract]   [Full Text] [Related]  

  • 6. Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study.
    Vokes EE; O'Brien SM; Vogelzang NJ; Schilsky RL; Ratain MJ
    Cancer Chemother Pharmacol; 1993; 32(5):347-52. PubMed ID: 8339384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil (5FU) with or without folinic acid (LV) in human colorectal cancer? Multivariate meta-analysis of the literature.
    Brohée D
    Med Oncol Tumor Pharmacother; 1991; 8(4):271-80. PubMed ID: 1840305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study.
    Vokes EE; Raschko JW; Vogelzang NJ; Warfield EE; Ratain MJ; Doroshow JH; Schilsky RL
    Cancer Chemother Pharmacol; 1991; 28(1):69-73. PubMed ID: 1828191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug treatment of colorectal cancer. Current status.
    Saltz L
    Drugs; 1991 Oct; 42(4):616-27. PubMed ID: 1723364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
    Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK
    J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double modulation of 5-fluorouracil in the treatment of advanced colorectal carcinoma: report of a trial with sequential methotrexate, intravenous (loading dose) folinic acid, 5-fluorouracil, and a literature review.
    Balaban EP; Graham M; Perkins S; Sheehan RG; Frenkel EP; Ross M; Bull J; Pruitt B; Periman P; Ruud C
    Cancer Invest; 1994; 12(1):12-9. PubMed ID: 8281461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group
    J Clin Oncol; 1989 Oct; 7(10):1437-46. PubMed ID: 2674332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
    Glimelius B
    Ann Oncol; 1993 Mar; 4(3):235-40. PubMed ID: 8471555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
    Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.